Cargando…

Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy

AIMS/HYPOTHESIS: Hyper-reflective crystalline deposits found in retinal lesions have been suggested to predict the progression of diabetic retinopathy, but the nature of these structures remains unknown. METHODS: Scanning electron microscopy and immunohistochemistry were used to identify cholesterol...

Descripción completa

Detalles Bibliográficos
Autores principales: Hammer, Sandra S., Dorweiler, Tim F., McFarland, Delaney, Adu-Agyeiwaah, Yvonne, Mast, Natalia, El-Darzi, Nicole, Fortmann, Seth D., Nooti, Sunil, Agrawal, Devendra K., Pikuleva, Irina A., Abela, George S., Grant, Maria B., Busik, Julia V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390399/
https://www.ncbi.nlm.nih.gov/pubmed/37311879
http://dx.doi.org/10.1007/s00125-023-05949-w
_version_ 1785082469405425664
author Hammer, Sandra S.
Dorweiler, Tim F.
McFarland, Delaney
Adu-Agyeiwaah, Yvonne
Mast, Natalia
El-Darzi, Nicole
Fortmann, Seth D.
Nooti, Sunil
Agrawal, Devendra K.
Pikuleva, Irina A.
Abela, George S.
Grant, Maria B.
Busik, Julia V.
author_facet Hammer, Sandra S.
Dorweiler, Tim F.
McFarland, Delaney
Adu-Agyeiwaah, Yvonne
Mast, Natalia
El-Darzi, Nicole
Fortmann, Seth D.
Nooti, Sunil
Agrawal, Devendra K.
Pikuleva, Irina A.
Abela, George S.
Grant, Maria B.
Busik, Julia V.
author_sort Hammer, Sandra S.
collection PubMed
description AIMS/HYPOTHESIS: Hyper-reflective crystalline deposits found in retinal lesions have been suggested to predict the progression of diabetic retinopathy, but the nature of these structures remains unknown. METHODS: Scanning electron microscopy and immunohistochemistry were used to identify cholesterol crystals (CCs) in human donor, pig and mouse tissue. The effects of CCs were analysed in bovine retinal endothelial cells in vitro and in db/db mice in vivo using quantitative RT-PCR, bulk RNA sequencing, and cell death and permeability assays. Cholesterol homeostasis was determined using (2)H(2)O and (2)H(7)-cholesterol. RESULTS: We identified hyper-reflective crystalline deposits in human diabetic retina as CCs. Similarly, CCs were found in the retina of a diabetic mouse model and a high-cholesterol diet-fed pig model. Cell culture studies demonstrated that treatment of retinal cells with CCs can recapitulate all major pathogenic mechanisms leading to diabetic retinopathy, including inflammation, cell death and breakdown of the blood–retinal barrier. Fibrates, statins and α-cyclodextrin effectively dissolved CCs present in in vitro models of diabetic retinopathy, and prevented CC-induced endothelial pathology. Treatment of a diabetic mouse model with α-cyclodextrin reduced cholesterol levels and CC formation in the retina, and prevented diabetic retinopathy. CONCLUSIONS/INTERPRETATION: We established that cholesterol accumulation and CC formation are a unifying pathogenic mechanism in the development of diabetic retinopathy. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version of this article (10.1007/s00125-023-05949-w) contains peer-reviewed but unedited supplementary material.
format Online
Article
Text
id pubmed-10390399
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-103903992023-08-02 Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy Hammer, Sandra S. Dorweiler, Tim F. McFarland, Delaney Adu-Agyeiwaah, Yvonne Mast, Natalia El-Darzi, Nicole Fortmann, Seth D. Nooti, Sunil Agrawal, Devendra K. Pikuleva, Irina A. Abela, George S. Grant, Maria B. Busik, Julia V. Diabetologia Article AIMS/HYPOTHESIS: Hyper-reflective crystalline deposits found in retinal lesions have been suggested to predict the progression of diabetic retinopathy, but the nature of these structures remains unknown. METHODS: Scanning electron microscopy and immunohistochemistry were used to identify cholesterol crystals (CCs) in human donor, pig and mouse tissue. The effects of CCs were analysed in bovine retinal endothelial cells in vitro and in db/db mice in vivo using quantitative RT-PCR, bulk RNA sequencing, and cell death and permeability assays. Cholesterol homeostasis was determined using (2)H(2)O and (2)H(7)-cholesterol. RESULTS: We identified hyper-reflective crystalline deposits in human diabetic retina as CCs. Similarly, CCs were found in the retina of a diabetic mouse model and a high-cholesterol diet-fed pig model. Cell culture studies demonstrated that treatment of retinal cells with CCs can recapitulate all major pathogenic mechanisms leading to diabetic retinopathy, including inflammation, cell death and breakdown of the blood–retinal barrier. Fibrates, statins and α-cyclodextrin effectively dissolved CCs present in in vitro models of diabetic retinopathy, and prevented CC-induced endothelial pathology. Treatment of a diabetic mouse model with α-cyclodextrin reduced cholesterol levels and CC formation in the retina, and prevented diabetic retinopathy. CONCLUSIONS/INTERPRETATION: We established that cholesterol accumulation and CC formation are a unifying pathogenic mechanism in the development of diabetic retinopathy. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version of this article (10.1007/s00125-023-05949-w) contains peer-reviewed but unedited supplementary material. Springer Berlin Heidelberg 2023-06-14 2023 /pmc/articles/PMC10390399/ /pubmed/37311879 http://dx.doi.org/10.1007/s00125-023-05949-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Hammer, Sandra S.
Dorweiler, Tim F.
McFarland, Delaney
Adu-Agyeiwaah, Yvonne
Mast, Natalia
El-Darzi, Nicole
Fortmann, Seth D.
Nooti, Sunil
Agrawal, Devendra K.
Pikuleva, Irina A.
Abela, George S.
Grant, Maria B.
Busik, Julia V.
Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy
title Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy
title_full Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy
title_fullStr Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy
title_full_unstemmed Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy
title_short Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy
title_sort cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390399/
https://www.ncbi.nlm.nih.gov/pubmed/37311879
http://dx.doi.org/10.1007/s00125-023-05949-w
work_keys_str_mv AT hammersandras cholesterolcrystalformationisaunifyingpathogenicmechanisminthedevelopmentofdiabeticretinopathy
AT dorweilertimf cholesterolcrystalformationisaunifyingpathogenicmechanisminthedevelopmentofdiabeticretinopathy
AT mcfarlanddelaney cholesterolcrystalformationisaunifyingpathogenicmechanisminthedevelopmentofdiabeticretinopathy
AT aduagyeiwaahyvonne cholesterolcrystalformationisaunifyingpathogenicmechanisminthedevelopmentofdiabeticretinopathy
AT mastnatalia cholesterolcrystalformationisaunifyingpathogenicmechanisminthedevelopmentofdiabeticretinopathy
AT eldarzinicole cholesterolcrystalformationisaunifyingpathogenicmechanisminthedevelopmentofdiabeticretinopathy
AT fortmannsethd cholesterolcrystalformationisaunifyingpathogenicmechanisminthedevelopmentofdiabeticretinopathy
AT nootisunil cholesterolcrystalformationisaunifyingpathogenicmechanisminthedevelopmentofdiabeticretinopathy
AT agrawaldevendrak cholesterolcrystalformationisaunifyingpathogenicmechanisminthedevelopmentofdiabeticretinopathy
AT pikulevairinaa cholesterolcrystalformationisaunifyingpathogenicmechanisminthedevelopmentofdiabeticretinopathy
AT abelageorges cholesterolcrystalformationisaunifyingpathogenicmechanisminthedevelopmentofdiabeticretinopathy
AT grantmariab cholesterolcrystalformationisaunifyingpathogenicmechanisminthedevelopmentofdiabeticretinopathy
AT busikjuliav cholesterolcrystalformationisaunifyingpathogenicmechanisminthedevelopmentofdiabeticretinopathy